These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9703921

  • 1. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J.
    Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
    [Abstract] [Full Text] [Related]

  • 2. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 3. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.
    Cancer Res; 1998 Jul 15; 58(14):3015-20. PubMed ID: 9679965
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3 expression in papillary microcarcinoma of the thyroid.
    Cvejic D, Savin S, Petrovic I, Paunovic I, Tatic S, Krgovic K, Havelka M.
    Histopathology; 2005 Aug 15; 47(2):209-14. PubMed ID: 16045783
    [Abstract] [Full Text] [Related]

  • 5. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan 15; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 6. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW.
    Histopathology; 2004 Nov 15; 45(5):493-500. PubMed ID: 15500653
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC, el-Naggar AK, Lotan R.
    Am J Pathol; 1995 Sep 15; 147(3):815-22. PubMed ID: 7677193
    [Abstract] [Full Text] [Related]

  • 8. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E.
    Hum Pathol; 2000 Apr 15; 31(4):428-33. PubMed ID: 10821488
    [Abstract] [Full Text] [Related]

  • 9. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Hum Pathol; 2008 Nov 15; 39(11):1656-63. PubMed ID: 18657294
    [Abstract] [Full Text] [Related]

  • 10. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M, Kapila K, Verma K.
    Indian J Pathol Microbiol; 2006 Jul 15; 49(3):376-80. PubMed ID: 17001889
    [Abstract] [Full Text] [Related]

  • 11. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
    Weinberger PM, Adam BL, Gourin CG, Moretz WH, Bollag RJ, Wang BY, Liu Z, Lee JR, Terris DJ.
    Arch Otolaryngol Head Neck Surg; 2007 May 15; 133(5):503-10. PubMed ID: 17515507
    [Abstract] [Full Text] [Related]

  • 12. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.
    Singapore Med J; 2008 Apr 15; 49(4):333-8. PubMed ID: 18418527
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.
    Pol J Pathol; 2003 Apr 15; 54(2):111-5. PubMed ID: 14575419
    [Abstract] [Full Text] [Related]

  • 14. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD.
    J Clin Endocrinol Metab; 2002 Oct 15; 87(10):4792-6. PubMed ID: 12364475
    [Abstract] [Full Text] [Related]

  • 15. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications.
    Rorive S, Eddafali B, Fernandez S, Decaestecker C, André S, Kaltner H, Kuwabara I, Liu FT, Gabius HJ, Kiss R, Salmon I.
    Mod Pathol; 2002 Dec 15; 15(12):1294-301. PubMed ID: 12481010
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Exp Oncol; 2006 Mar 15; 28(1):70-4. PubMed ID: 16614712
    [Abstract] [Full Text] [Related]

  • 17. Galectin-3 is not useful in thyroid FNA.
    Mills LJ, Poller DN, Yiangou C.
    Cytopathology; 2005 Jun 15; 16(3):132-8. PubMed ID: 15924608
    [Abstract] [Full Text] [Related]

  • 18. Retinoblastoma expression in thyroid neoplasms.
    Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP.
    Mod Pathol; 2000 May 15; 13(5):562-9. PubMed ID: 10824929
    [Abstract] [Full Text] [Related]

  • 19. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.
    Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Yasuoka H, Kakudo K, Inohara H, Kuma K, Miyauchi A.
    Pathology; 2005 Aug 15; 37(4):296-8. PubMed ID: 16194828
    [Abstract] [Full Text] [Related]

  • 20. [Expression of galectin-3 in thyroid gland and follicular cell tumors of the thyroid. A critical study of its possible role in preoperative differential diagnosis].
    Niedobitek C, Niedobitek F, Lindenberg G, Bachler B, Neudeck H, Zuschneid W, Hopfenmüller W.
    Pathologe; 2001 May 15; 22(3):205-13. PubMed ID: 11402851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.